Inventor

Lisa McConlogue

Inventor

Burlingame, CA, US

Overview

1997–2010

Patent span

Chemistry

Primary field (CPC C)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary

C12NMicroorganisms or enzymes28%

A01KAnimal husbandry20%

A61KPreparations for medical, dental or toiletry purposes14%

C07KPeptides14%

G01NInvestigating or analysing materials by determining their chemical or physical properties8%

H01QAntennas, i.e. radio aerials7%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations4%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%

C12YEnzymes1%

PatentTitleYear

7,718,413'Glycosylation variants of BACE'2010 7,608,749'Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation'2009 7,482,136'Glycosylation variants of BACE'2009 7,456,007'Î²-secretase enzyme compositions and methods'2008 7,427,478'Beta-secretase enzyme compositions and methods'2008 7,276,349'Beta-secretase enzyme compositions and methods'2007 7,262,043'Î²-secretase enzyme compositions and methods'2007 7,252,963'Î²-secretase enzyme compositions and methods'2007 7,186,881'Testing compounds for effects on synaptophysin in transgenic mice expressing an Alzheimer\'s disease FAD DNA sequence'2007 7,179,953'Monitoring APP cleavage in transgenic rodents comprising an APP-Swedish mutation'2007 7,115,410'Î²-secretase enzyme compositions and methods'2006 7,109,017'Î²-secretase enzyme compositions and methods'2006 7,067,271'Î²-secretase enzyme compositions and methods'2006 6,852,482'Methods and compositions for inhibiting Î²-secretase'2005 6,664,442'Selecting compounds to reduce inflammation associated with Alzheimer\'s disease'2003 6,627,739'-secretase enzyme compositions and methods'2003 6,221,645'.beta.-secretase antibody'2001 5,849,711'Cathepsin and methods and compositions for inhibition thereof'1998 5,783,434'Cathepsin and methods and compositions for inhibition thereof'1998 5,612,486'Transgenic animals harboring APP allele having swedish mutation'1997 5,604,102'Methods of screening for .beta.-amyloid peptide production inhibitors'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–1998Patents assigned to ATHENA NEUROSCIENCES INC (3)· patent assignee history

1997–2009Patents assigned to LILLY CO ELI (3)· patent assignee history

1997–2007Based in San Francisco, CA, US· patent location history

2001–2010Patents assigned to ELAN PHARM INC (16)· patent assignee history

2003–2010Based in Burlingame, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ELAN PHARM INC	16	2001–2010
ATHENA NEUROSCIENCES INC	3	1997–1998
LILLY CO ELI	3	1997–2009

Locations

Location	Patents	Span
Burlingame, California, US	13	2003–2010
San Francisco, California, US	8	1997–2007